Immunoprofiling analysis services
Protobios is positioning itself as a developer of new diagnostic biomarkers and immunotherapy drugs providing services in the field of immunome analysis.
PROTOBIOS
Immunoprofiling analysis services
Protobios is at the forefront of harnessing immune intelligence to develop next-generation diagnostic biomarkers and immunotherapy drugs. Through advanced immunome analysis, we transform complex immune data into actionable insights that drive precision medicine forward.
Over the years, we have made substantial contributions to advancing the understanding of immune systems and developing innovative tools in medical biology and immunology. Guided by a deep commitment to scientific excellence, we continue to explore novel solutions that unlock the full potential of immune intelligence.
We welcome collaborations and partnerships that share our vision—combining expertise, technology, and creativity to shape the future of immune-driven diagnostics and therapies. Together, we aim to accelerate the discovery of groundbreaking innovations that improve human health and well-being.
Immune Profiling
Analyzes the body’s immune activity through comprehensive antibody response analysis. Our immune profiling solutions provide a high-resolution view of immune dynamics, enabling researchers and clinicians to decode complex immune mechanisms and accelerate breakthroughs in discovery and care.
Biomarker Discovery
Focuses on identifying and validating antibody epitopes as key indicators of immune function and disease states. By uncovering novel biomarkers, we support the development of more precise diagnostic tools and targeted therapeutic strategies.
Precision Immunology
Conveys a personalized approach to understanding and modulating antibody-driven immune responses. Through advanced analytics and profiling, we help translate immune insights into tailored interventions and improved patient outcomes.
SERVICES
Protobios services
Protobios offers a range of MVA technology-driven services, including epitope mapping, antibody-targeted antigen profile analyses, and immunogenicity assessments, all tailored to meet the needs of the customers from applied research groups to the biotech industry. Kindly use the CONTACTS section for service inquiries.
PARTNERS
Our Partners
Protobios works with leading universities, hospitals, and research consortia across Europe to advance precision medicine and digital health. Together, we develop innovative solutions such as digital twin ecosystems, decision support systems for Long COVID, and AI-driven tools for predicting antidepressant efficacy. Our collaborations also explore the immune system’s role in neurological and psychiatric disorders, providing new insights into treatment opportunities. A cornerstone of these projects is our patented Mimotope Variation Analysis (MVA) technology, which enables large-scale antibody profiling and a deeper understanding of immune responses. Through these partnerships, Protobios contributes to predictive, preventive, personalized, and participatory healthcare.
BLOG
Explore our latest insights on biomarker development